Advertisement

Topics

Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX® ...

08:00 EDT 24 Aug 2017 | BioMedReports - Blog

"With this additional Medicare coverage we can now broaden the impact of Oncotype DX, the only genomic test validated to predict both the current risk

Read more...

Original Article: Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX® ...

NEXT ARTICLE

More From BioPortfolio on "Medicare Establishes Final Local Coverage Determination (LCD) for Use of the Oncotype DX® ..."

Advertisement
Quick Search
Advertisement
Advertisement